These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 18799567)

  • 1. Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.
    Wu Q; Qian W; Sun X; Jiang S
    J Hematol Oncol; 2022 Oct; 15(1):143. PubMed ID: 36209184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant Mucous Cells in a Thyroid Aspirate: Looking for a Source.
    Fontanella S; Bongiovanni M; Nobile A; Uccella S; Mazzucchelli L; Espeli V; Giovanella L
    Endocr Pathol; 2016 Mar; 27(1):79-82. PubMed ID: 26475625
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.
    Ladenson PW; Braverman LE; Mazzaferri EL; Brucker-Davis F; Cooper DS; Garber JR; Wondisford FE; Davies TF; DeGroot LJ; Daniels GH; Ross DS; Weintraub BD
    N Engl J Med; 1997 Sep; 337(13):888-96. PubMed ID: 9302303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 2)].
    Dietlein M; Dressler J; Eschner W; Leisner B; Reiners C; Schicha H; ;
    Nuklearmedizin; 2003 Jun; 42(3):123-5. PubMed ID: 12802477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faster radioiodine washout in the treatment of pulmonary metastases of papillary thyroid cancer prepared with recombinant human thyroid-stimulating hormone.
    Hung GU; Ho M; Kao CH
    Clin Nucl Med; 2009 May; 34(5):316-7. PubMed ID: 19387216
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of poorly differentiated thyroid cancer with radioiodine scanning after thyrotropin alfa stimulation.
    Juweid M; O'Dorisio T; Milhem M
    N Engl J Med; 2008 Sep; 359(12):1295-7. PubMed ID: 18799567
    [No Abstract]   [Full Text] [Related]  

  • 7. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
    Salvatori M; Biondi B; Rufini V
    Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual and recurrent thyroid cancer by radionuclide imaging.
    Maxon HR
    Thyroid; 1999 May; 9(5):443-6. PubMed ID: 10365674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear medicine in the assessment of differentiated thyroid cancer.
    Rutherford GC; Franc B; O'Connor A
    Clin Radiol; 2008 Apr; 63(4):453-63. PubMed ID: 18325367
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.